To The Moon

Cathie Wood’s Ark Invest has made some notable moves, buying more shares of $Archer Aviation Inc.(ACHR)$ and $Rocket Lab USA, Inc.(RKLB)$ while reducing its position in Chinese electric vehicle giant $BYD Co., Ltd.(BYDDY)$ 

The transactions highlight three very different investment themes: electric vehicles, autonomous aviation and commercial space. But what might Ark be seeing in these companies, and should investors pay attention?

1. BYD: Strong growth, but are expectations getting too high?

Ark sold a combined 352,886 BYD shares over two sessions through its ARK Autonomous Technology & Robotics ETF. Based on the supplied prices, the sales were worth approximately US$3.1 million.

The timing is interesting because BYD’s latest third-quarter results still showed business growth.

Net profit increased 28% to CNY 10 billion, while revenue rose 13.6% to CNY 221.5 billion. Overseas vehicle shipments more than doubled, demonstrating the company’s expanding international presence.

However, its profit fell short of brokerage forecasts compiled by Reuters.

This is an important distinction. A company can report strong year-on-year growth but still disappoint investors if results do not meet expectations.

BYD also faces intense competition in the electric vehicle market, particularly in China, where pricing pressure can affect margins.

Ark’s sales do not necessarily mean it has lost confidence in BYD. They could reflect profit-taking, portfolio rebalancing or a decision to allocate capital to other opportunities.

2. Archer Aviation: Betting on the future of air mobility

While reducing BYD exposure, Ark purchased approximately 1.69 million Archer shares over two sessions, worth around US$8 million based on the supplied prices.

Archer is developing electric vertical take-off and landing aircraft, commonly known as eVTOLs. The long-term ambition is to introduce a new form of urban and regional transportation.

Its latest quarterly results were mixed. Revenue of US$5.1 million exceeded analyst expectations of US$3.57 million, but its loss of US$0.35 per share was slightly wider than the expected US$0.34.

Analysts also adjusted their expectations. Cantor Fitzgerald maintained an Overweight rating but reduced its price target from US$11 to US$10. Needham retained its Buy rating while lowering its target from US$9 to US$7.

The opportunity is potentially significant, but Archer remains a development-stage business. Investors need to monitor aircraft certification, commercial launch timelines, production costs and cash requirements.

The biggest challenge is turning an exciting aviation concept into a safe, commercially viable service.

3. Rocket Lab: Space infrastructure is attracting attention

Ark also purchased 72,709 Rocket Lab shares across two sessions, worth approximately US$4.6 million using the supplied prices.

Rocket Lab’s investment case is different from Archer’s. It already operates launch services and is developing its larger Neutron rocket to compete for more demanding missions.

The company has a reported backlog of approximately US$3.6 billion. Its base price for a Neutron launch increased from US$55 million to US$70 million.

Another development attracting attention is tightening launch capacity. Cantor Fitzgerald analyst Andres Sheppard noted that SpaceX was no longer accepting commercial Falcon 9 bookings beyond 2028. If launch capacity remains constrained, Rocket Lab could have an opportunity to strengthen its pricing position.

However, there is an important risk: Neutron’s debut has moved into 2027 following a manufacturing issue.

A large backlog is encouraging, but investors still need to see successful launches, reliable execution and improved financial performance.

4. What do Ark’s trades tell us?

The interesting part is not simply that Ark sold BYD and bought Archer and Rocket Lab. It is the contrast between the businesses.

BYD operates in an established and highly competitive vehicle market. Archer is targeting a new aviation market that still needs regulatory and commercial validation. Rocket Lab is building a position in the growing space economy, where launch capacity and execution are critical.

These are very different risk profiles.

Ark’s purchases suggest continued interest in companies developing technologies that could reshape transportation and infrastructure. However, its transactions should not be treated as proof that these stocks are undervalued or guaranteed to succeed.

My view

I find Rocket Lab particularly interesting because it has an operating launch business, an existing backlog and a larger rocket programme that could expand its addressable market. However, the Neutron delay remains a risk that investors should not ignore.

Archer offers exposure to a potentially transformative aviation market, but its path to commercial operations is still uncertain. BYD, meanwhile, has an established vehicle business and significant overseas growth opportunities, despite the earnings disappointment.

I would focus less on copying Ark’s trades and more on what each company delivers over the next few quarters.

For Rocket Lab, watch Neutron development and launch execution. For Archer, watch certification and commercial progress. For BYD, watch overseas growth and profit margins.

Ark may be rotating its portfolio, but the real test for all three companies will be whether their long-term ambitions translate into sustainable earnings.

For discussion purposes only.